| |DECEMBER 202419and final reporting. She is proficient in conducting comprehensive gap analyses and developing remediation plans to ensure systems are audit-ready."An increased demand of experienced and expert personnel can be observed arising from different sectors of the health and wellness ecosystem including pharmaceuticals, biotech, biopharmaceuticals, and nutraceuticals. New molecules are coming into the scenario in terms of cell and gene therapies, targeted treatments, and likewise. We are completely equipped to support facility development, characterization and validation of the molecules, end to end quality consulting and implementation support in all the sectors of the industry", mentioned Aditi.Focus on CustomizationWith the rise in the number of targeted therapies, new trends in manufacturing and testing are also entering the industry. New regulatory standards are being set by medical authorities across the world regarding manufacturing and quality management systems and compliances. In many cases, it can be seen that despite having an effective product, a manufacturer is unable to scale up production because of a lack of new technologies and their effective use. AVChiT Biosolutions' team of experts have all the required knowledge about the latest products and technologies coming into the industry and are also aware of the quality and regulatory standards that manufacturers need to live up to gain sustainability in the market."Many a times, what comes to light are clients requiring consultancy regarding product purification processes to accurately comply with the regulatory standards. Our capabilities equip us to provide end-to-end solutions in these areas and inspect all parameters required in such facilities. Based on the need and specific requirement, we support troubleshooting of pain points, improvisation in yields or a complete transformation of the process into latest and cost-effective technologies. We are focusing a lot on customized services because of the changing dynamics of the industry", said Aditi. Future ProjectionsSince its inception in 2022, the company has gained considerable trust in the market because of its immense experience, delivering on timelines and value for money solutions. It is currently serving clients from various sectors like education, research, nutraceuticals, and medical consumables industry. Aditi has worked on various elaborate projects in biopharmaceuticals consultancy. AVChiT Biosolutions has demonstrated effective quality management system development, implementation and support on day to day activities. The same has been appreciated by regulatory bodies, customers and auditors alike.Looking ahead, AVChiT Biosolutions aims to expand its client base and provide comprehensive consultancy services across the biopharmaceuticals, vaccines, and biologics sectors. Its commitment to delivering solutions that are compliant with current regulatory requirements, while prioritizing user experience and operational efficiency, distinguishes AVChiT Biosolutions apart as a biopharmaceutical consultancy. "We are dedicated to collaborating on projects to ensure timely delivery and excellence. AVChiT is eager to work with a diverse range of clients, from small and large manufacturing setups to startups and entrepreneurs. Our goal is to become one of the most trusted consultants in this domain", concluded Aditi. PO
< Page 9 | Page 11 >